1. home
  2. 企業
  3. SKYER, Inc.

SKYER, Inc.

大韓民国

私たちについて

For the past 100 years, the world's population has increased by 1 billion every 13 years. As the population grows, an ecosystem has been changed. The traditional buffer zones that separate humans from animals or from the pathogens that they harbor are notably reduced. And inevitably, the frequency and prevalence of these infectious diseases, defined as ‘zoonosis’, have increased. The most effective way to minimize damages from zoonotic diseases is to detect them earlier.

Born in 2010, SKYER develops and produces high-quality and highly efficient antigen-antibody reaction test kits that have shown consistent sensitivity, specificity, and accuracy. And we will continue our effort to make faster and more accurate test kits by integrating advanced materials and technologies into our system.

私たちの価値観

We believe rapid tests (also known as lateral flow assays - LFAs - or immunochromatographic strip tests - ICTs), especially in the Point-of-Care Test (POCT), are crucial for managing zoonotic pandemics with the lowest cost.

SKYER pursues creative ideas, open-mindedness, infinite opportunities, and diversity to create a world where humans and nature coexist more safely.

*価格には税、配送費、関税また設置・作動のオプションに関する全ての追加費用は含まれておりません。表示価格は、国、原材料のレート、為替相場により変動することがあります。
MedicalExpoについて
MedicalExpoは、B2Bの企業に製品調達から購入までの完全な体験を提供するマーケットプレイスです。MedicalExpoはVirtualExpo Groupの事業体です。